The Indian vaccine market predicted to be worth Rs 252 billion by 2025, Union Minister

The Indian vaccine market predicted to be worth Rs 252 billion by 2025, Union Minister

India has already established a presence at the international level and is becoming a leader in preventive healthcare, with Minister of State for Science and Technology Jitendra Singh recently announcing that the country's vaccine market is expected to reach a Rs 252 billion valuation by 2025. 

 

The Minister quoted India's development of four indigenous vaccines in the last two years. He further highlighted the achievements of the "Mission Covid Suraksha" initiative, which has delivered four vaccines, augmented the manufacturing of Covaxin, and established the necessary infrastructure for the development of future vaccines. Mr. Singh stated, "India has already developed a nasal COVID vaccine and a vaccine related to Human Papillomavirus (HPV), which could help prevent cervical cancer. India continues to make strides in the vaccine market, and its value is set to increase dramatically in the coming years." He also commented on India's exceptional abilities in preventive healthcare, noting that the country is currently creating multiple vaccines.

 

During his official visit to the United Kingdom, Singh expressed his desire for India and the UK to work together in the fields of biotech startups and vaccine development. 

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks